Experimental browser for the Atmosphere
The diabetes and weight loss drug semaglutide reversed signs of the liver disease MASH, results of a new clinical trial show.
May 7, 2025, 2:30 PM
{ "uri": "at://did:plc:mhjqpvjvyzpj4pso7ux2tekh/app.bsky.feed.post/3lolmei5scp2f", "cid": "bafyreih4eu5mfwastyapqcrjmktl6is7r5wkqonq7gmh6odqllzb3gt3xi", "value": { "text": "The diabetes and weight loss drug semaglutide reversed signs of the liver disease MASH, results of a new clinical trial show.", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://buff.ly/caz12mF", "thumb": { "$type": "blob", "ref": { "$link": "bafkreiauhhlgnhp6qcn4vo23lzjyyggj3z6pif5ozgiahuytyn2mvhuvde" }, "mimeType": "image/jpeg", "size": 110500 }, "title": "Ozempic and Wegovy ingredient may reverse signs of liver disease", "description": "The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH." } }, "createdAt": "2025-05-07T14:30:57.510Z" } }